文献速递皮肤肿瘤

RAC1靶点NCKAP1在Braf;Pten驱动的小鼠黑色素瘤进展中起关键作用

The RAC1 Target NCKAP1 Plays a Crucial Role in the Progression of Braf;Pten-Driven Melanoma in Mice.
PubMed 文献 · J Invest Dermatol · 2020-08-08

该研究在BRAFV600E;PTEN缺失驱动的黑色素瘤小鼠模型中,探讨RAC1下游SCAR/WAVE复合物亚基NCKAP1的作用。结果显示,在黑色素细胞谱系中靶向敲除Nckap1可延迟肿瘤发生与进展,肿瘤出现纤维化间质、胶原沉积增加及免疫浸润增强,且增殖与生长减慢,提示NCKAP1介导的肌动蛋白聚合对肿瘤进展和维持组织完整性至关重要。

要点

  • 在Braf;Pten驱动小鼠黑色素瘤模型中,Nckap1敲除延迟肿瘤发生与进展。
  • Nckap1缺失肿瘤表现为纤维化间质、胶原沉积增加及免疫浸润增强。
  • Nckap1缺失减慢增殖与肿瘤生长,提示其在细胞周期进展中的作用。

核心结论

  • NCKAP1编排的肌动蛋白聚合对Braf;Pten缺失驱动的小鼠黑色素瘤进展和维持肿瘤组织完整性至关重要。

研究设计与样本

  • 研究使用BRAFV600E;PTEN缺失驱动的黑色素瘤小鼠模型,在黑色素细胞谱系中靶向敲除Nckap1。

主要发现

  • Nckap1靶向缺失延迟了Braf;Pten缺失驱动黑色素瘤小鼠模型的肿瘤发生和进展。
  • Nckap1缺失的肿瘤显示纤维化间质、胶原沉积增加,并伴有免疫浸润增强。
  • Nckap1缺失减缓增殖和肿瘤生长,提示其在细胞周期进展中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BRAFV600E is the most common driver mutation in human cutaneous melanoma and is frequently accompanied by loss of the tumor-suppressing phosphatase PTEN. Recent evidence suggests a co-operative role for RAC1 activity in BRAFV600E-driven melanoma progression and drug resistance. However, the underlying molecular mechanisms and the role of RAC1 downstream targets are not well-explored. In this study, we examine the role of the NCKAP1 subunit of the pentameric cytoskeletal SCAR/WAVE complex, a major downstream target of RAC1, in a mouse model of melanoma driven by BRAFV600E;PTEN loss. The SCAR/WAVE complex is the major driver of lamellipodia formation and cell migration downstream of RAC1 and depends on NCKAP1 for its integrity. Targeted deletion of Nckap1 in the melanocyte lineage delayed tumor onset and progression of a mutant Braf;Pten loss‒driven melanoma mouse model. Nckap1-depleted tumors displayed fibrotic stroma with increased collagen deposition concomitant with enhanced immune infiltration. Nckap1 loss slowed proliferation and tumor growth, highlighting a role in cell-cycle progression. Altogether, we propose that NCKAP1-orchestrated actin polymerization is essential for tumor progression and maintenance of tumor tissue integrity in a mutant Braf/Pten loss‒driven mouse model for melanoma.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Swaminathan K, Campbell A, Papalazarou V, et al. The RAC1 Target NCKAP1 Plays a Crucial Role in the Progression of Braf;Pten-Driven Melanoma in Mice. J Invest Dermatol. 2020. PMID: 32777214. doi:10.1016/j.jid.2020.06.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。